JACC. Cardiovascular interventionsHumansMaleProspective StudiesFemaleHeart Valve Prosthesis
Mid-Term Outcomes of a Novel TAVR Device for Pure Aortic Regurgitation: A Prospective, Multicenter Trial.
Bowen Xiao, Lulu Liu, Yansong Guo, Jian Liu, Pengwei Yang, Yingbin Xiao, Jiancheng Xiu, Junjie Zhang, Zhenfei Fang, Gejun Zhang, Hong Jiang, Jinping Liu, Xianbao Liu, Yangyang Shen, Jian Yang
Published: 202510.1016/j.jcin.2025.10.017
Abstract
BACKGROUND: Patients with severe aortic regurgitation (AR) frequently face high surgical risks, rendering them ineligible for surgery. Transcatheter aortic valve replacement (TAVR) is now a primary therapy for aortic valve stenosis. However, its appl…
Preview only. Read the full abstract at the source